Back to 
Vanguard Group Inc.
Vanguard Group Inc.
HCWB
2 quarters
Position history for Vanguard Group Inc.'s holdings in HCW Biologics Inc.
As of its last 13F, for Q4 2025, Vanguard Group held 15,426 shares of HCWB (HCW Biologics), worth $14,979. The share count is unchanged from Q3 2025. Vanguard Group held HCWB from Q3 2025 to Q4 2025, across 2 quarterly 13F filings.
Current Value
$14,979
Current Shares
15,426
Total Value Change
-$42,097
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of HCWB: HRT Financial LP, Geode Capital Management, LLC, UBS Group AG, Citadel Advisors LLC, Susquehanna International Group, LLP